Home > About us

About us

Our purpose

We have an active and crucial role in raising standards of everyday life, in making people healthier, happier and safer.

The Group has a leading market position in Bulgaria
contributing to 78.7% of its sales of health related products
Our products are available on over 45 export markets
5,075
employees work for us
We have more than 7000 shareholders

Message of the CEO

ceo

Dear shareholders, dear friends, 

Let us wish we are all healthy in 2020!

The management of “Sopharma” AD is determined to re-examine the Company's strategy in the context of sustainable development. As a zero-carbon company, we turn our eyes to the broader footprint that our business and our employees leave in the environment. With the construction of the new plant for solid dosage forms in Sofia, we ceased the use of organic substances in film-coated tablets, thus eliminating the need for energy-intensive and expensive water treatment and waste-water pollution. Sopharma Group is also a responsible farmer - in 2018, nearly 700,000 yellow acacia saplings were planted, the seeds of which are a raw material in the production of one of our main products Tabex for smoking cessation. We are about to plant another 300,000 trees in the spring of 2020, and in the process we have revived a number of small communities.

Interested current and future investors are eagerly awaiting the implementation of the single financial reporting system of the long-awaited EP and Council Taxonomy, which will allow private capital to be invested exclusively in economic activities that are truly sustainable.

Our economic footprint has grown in key indicators such as dividends paid, taxes paid and corporate tax, staff payments, etc.

In December 2019, we realized a 16% increase in sales compared to the same month of the previous year, and for the whole year the sales revenue increased by 9% compared to 2018, which is mainly due to a 15% increase in export sales to the main foreign markets.

We believe that all the steps we have taken will guarantee us another successful year.

Thank you for your support and trust.

Ognian Donev, PhD
Chairman of the Board of Directors and Executive Director of Sopharma AD

 

Our idea of responsible business
  • The social role of our generic medicines
  • Employment
  • Investments
  • Social diseases responsibility
  • Energy efficiency and low environmental impact
  • National responsible producer